Reference
Yamazaki N, et al. Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma. Journal of Dermatology 50: 1108-1120, No. 9, Sep 2023. Available from: URL: 10.1111/1346-8138.16820
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 2007, 268 (2024). https://doi.org/10.1007/s40278-024-58828-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58828-x